CSL Limited Stock (ASX: CSL): Buyback Update, Analyst Forecasts, and the Key Catalysts Shaping the CSL Share Price on 18 December 2025
CSL Limited (ASX: CSL) spent much of 2025 reminding investors of a brutal truth: even world-class biopharma franchises can get whacked when costs, policy, and sentiment all lean the wrong way at the same time. On 18 December 2025, the CSL share price was A$174.57 (delayed), up 0.68% on the day after trading between A$171.64 and A$174.65. Intelligent Investor The day’s most concrete “fresh” news is a buyback update—but the real story investors are pricing is broader: the post-pandemic reset in flu vaccination demand (and politics around vaccines), margin recovery in plasma, China-linked albumin uncertainty, and whether CSL’s cost-and-capital reset